• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒病严重程度与心血管疾病及其传统危险因素的关系:系统评价和荟萃分析。

The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-Analysis.

机构信息

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, US.

Welch Center for Prevention, Epidemiology, and Clinical Research, US.

出版信息

Glob Heart. 2020 Sep 22;15(1):64. doi: 10.5334/gh.814.

DOI:10.5334/gh.814
PMID:33150129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7546112/
Abstract

BACKGROUND

Whether cardiovascular disease (CVD) and its traditional risk factors predict severe coronavirus disease 2019 (COVID-19) is uncertain, in part, because of potential confounding by age and sex.

METHODS

We performed a systematic review of studies that explored pre-existing CVD and its traditional risk factors as risk factors of severe COVID-19 (defined as death, acute respiratory distress syndrome, mechanical ventilation, or intensive care unit admission). We searched PubMed and Embase for papers in English with original data (≥10 cases of severe COVID-19). Using random-effects models, we pooled relative risk (RR) estimates and conducted meta-regression analyses.

RESULTS

Of the 661 publications identified in our search, 25 papers met our inclusion criteria, with 76,638 COVID-19 patients including 11,766 severe cases. Older age was consistently associated with severe COVID-19 in all eight eligible studies, with RR >~5 in >60-65 versus <50 years. Three studies showed no change in the RR of age after adjusting for covariate(s). In univariate analyses, factors robustly associated with severe COVID-19 were male sex (10 studies; pooled RR = 1.73, [95% CI 1.50-2.01]), hypertension (8 studies; 2.87 [2.09-3.93]), diabetes (9 studies; 3.20 [2.26-4.53]), and CVD (10 studies; 4.97 [3.76-6.58]). RR for male sex was likely to be independent of age. For the other three factors, meta-regression analyses suggested confounding by age. Only four studies reported multivariable analysis, but most of them showed adjusted RR ~2 for hypertension, diabetes, and CVD. No study explored renin-angiotensin system inhibitors as a risk factor for severe COVID-19.

CONCLUSIONS

Despite the potential for confounding, these results suggest that hypertension, diabetes, and CVD are independently associated with severe COVID-19 and, together with age and male sex, can be informative for predicting the risk of severe COVID-19.

摘要

背景

心血管疾病(CVD)及其传统危险因素是否可预测严重的 2019 冠状病毒病(COVID-19)尚不确定,部分原因是年龄和性别可能存在混杂因素。

方法

我们对探讨预先存在的 CVD 及其传统危险因素是否为严重 COVID-19(定义为死亡、急性呼吸窘迫综合征、机械通气或重症监护病房收治)危险因素的研究进行了系统回顾。我们在 PubMed 和 Embase 上检索了以英文发表的包含原始数据(≥10 例严重 COVID-19)的论文。我们使用随机效应模型汇总相对风险(RR)估计值并进行了荟萃回归分析。

结果

在我们的检索中,有 661 篇论文符合纳入标准,其中 25 篇论文符合纳入标准,涉及 76638 例 COVID-19 患者,包括 11766 例严重病例。在所有 8 项合格研究中,年龄较大均与所有严重 COVID-19 持续相关,60-65 岁与<50 岁相比 RR>5。有 3 项研究表明,在调整协变量后,年龄与 RR 无变化。在单变量分析中,与严重 COVID-19 显著相关的因素包括男性(10 项研究;汇总 RR=1.73[95%CI 1.50-2.01])、高血压(8 项研究;2.87[2.09-3.93])、糖尿病(9 项研究;3.20[2.26-4.53])和 CVD(10 项研究;4.97[3.76-6.58])。男性的 RR 可能与年龄无关。对于其他三个因素,荟萃回归分析表明存在年龄混杂。只有 4 项研究报告了多变量分析,但其中大多数研究显示高血压、糖尿病和 CVD 的校正 RR2。没有研究探讨肾素-血管紧张素系统抑制剂是否为严重 COVID-19 的危险因素。

结论

尽管存在混杂的可能性,但这些结果表明高血压、糖尿病和 CVD 与严重 COVID-19 独立相关,与年龄和男性性别一起,可提供预测严重 COVID-19 风险的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aae/7546112/6f77a4ba4160/gh-15-1-814-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aae/7546112/997d0c63ff8d/gh-15-1-814-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aae/7546112/725b64b3af66/gh-15-1-814-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aae/7546112/b118e6de35cf/gh-15-1-814-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aae/7546112/0c2cbe8dab19/gh-15-1-814-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aae/7546112/6f77a4ba4160/gh-15-1-814-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aae/7546112/997d0c63ff8d/gh-15-1-814-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aae/7546112/725b64b3af66/gh-15-1-814-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aae/7546112/b118e6de35cf/gh-15-1-814-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aae/7546112/0c2cbe8dab19/gh-15-1-814-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aae/7546112/6f77a4ba4160/gh-15-1-814-g5.jpg

相似文献

1
The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-Analysis.新型冠状病毒病严重程度与心血管疾病及其传统危险因素的关系:系统评价和荟萃分析。
Glob Heart. 2020 Sep 22;15(1):64. doi: 10.5334/gh.814.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis.糖尿病的风险表型与 COVID-19 严重程度和死亡的关系:一项实时系统评价和荟萃分析。
Diabetologia. 2021 Jul;64(7):1480-1491. doi: 10.1007/s00125-021-05458-8. Epub 2021 Apr 28.
4
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.血管紧张素-肾素-醛固酮系统抑制剂与 COVID-19 患者临床结局的相关性:系统评价和荟萃分析。
JAMA Netw Open. 2021 Mar 1;4(3):e213594. doi: 10.1001/jamanetworkopen.2021.3594.
5
Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.心血管合并症是 COVID-19 严重感染或死亡的预测因素。
Eur Heart J Qual Care Clin Outcomes. 2021 Mar 15;7(2):172-180. doi: 10.1093/ehjqcco/qcaa081.
6
Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression.脑血管病和心血管病对 COVID-19 死亡率和严重程度的影响:系统评价、荟萃分析和荟萃回归。
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104949. doi: 10.1016/j.jstrokecerebrovasdis.2020.104949. Epub 2020 May 14.
7
Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis.新型冠状病毒肺炎的流行病学、合并症因素与严重程度及预后:一项系统综述和荟萃分析
Aging (Albany NY). 2020 Jul 13;12(13):12493-12503. doi: 10.18632/aging.103579.
8
Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies.人口统计学因素与 COVID-19 感染、严重程度、重症监护病房入院和死亡的关系:59 项研究的荟萃分析。
BMJ Open. 2021 Jan 11;11(1):e044640. doi: 10.1136/bmjopen-2020-044640.
9
Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression.糖尿病与COVID-19肺炎患者的死亡率增加及疾病严重程度相关——一项系统评价、荟萃分析和Meta回归分析
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):395-403. doi: 10.1016/j.dsx.2020.04.018. Epub 2020 Apr 17.
10
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.阿司匹林用于心血管疾病和癌症一级预防的预防性使用:系统评价和综述概述。
Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430.

引用本文的文献

1
Impact of COVID-19 infection on mortality, diabetic complications and haematological parameters in patients with diabetes mellitus: a systematic review and meta-analysis.2019冠状病毒病感染对糖尿病患者死亡率、糖尿病并发症及血液学参数的影响:一项系统评价和荟萃分析
BMJ Open. 2025 Mar 27;15(3):e090986. doi: 10.1136/bmjopen-2024-090986.
2
Risk factors for disease progression and clinical outcomes in patients with COVID-19 in Taiwan: a nationwide population-based cohort study.台湾地区新冠肺炎患者疾病进展及临床结局的危险因素:一项基于全国人群的队列研究。
BMC Pulm Med. 2025 Jan 26;25(1):43. doi: 10.1186/s12890-024-03468-x.
3
Retrospective analysis of risk factors associated with mortality in hospitalized COVID-19 patients.

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
Kidney disease is associated with in-hospital death of patients with COVID-19.肾病与 COVID-19 患者住院期间的死亡相关。
Kidney Int. 2020 May;97(5):829-838. doi: 10.1016/j.kint.2020.03.005. Epub 2020 Mar 20.
3
Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.肾素-血管紧张素系统抑制在 COVID-19 大流行期间的争议。
住院COVID-19患者死亡相关危险因素的回顾性分析。
J Family Med Prim Care. 2024 Oct;13(10):4419-4423. doi: 10.4103/jfmpc.jfmpc_405_24. Epub 2024 Oct 18.
4
Intelligent cardiovascular disease diagnosis using deep learning enhanced neural network with ant colony optimization.基于深度强化学习和蚁群算法的神经网络在心血管疾病诊断中的应用
Sci Rep. 2024 Sep 18;14(1):21777. doi: 10.1038/s41598-024-71932-z.
5
Cardiovascular risk and the COVID-19 pandemic: a population-based and case‒control studies.心血管风险与 COVID-19 大流行:基于人群和病例对照的研究。
Popul Health Metr. 2024 Jul 19;22(1):18. doi: 10.1186/s12963-024-00338-w.
6
Early Effects of the COVID-19 Pandemic on Patients in a Virtual Multicenter Spontaneous Coronary Artery Dissection (SCAD) Registry.2019年冠状病毒病大流行对虚拟多中心自发性冠状动脉夹层(SCAD)登记处患者的早期影响
CJC Open. 2024 Jan 26;6(5):689-698. doi: 10.1016/j.cjco.2024.01.006. eCollection 2024 May.
7
A community health worker led approach to cardiovascular disease prevention in the UK-SPICES-Sussex (scaling-up packages of interventions for cardiovascular disease prevention in selected sites in Europe and Sub-saharan Africa): an implementation research project.在英国开展的由社区卫生工作者主导的心血管疾病预防方法——SPICES-苏塞克斯项目(在欧洲和撒哈拉以南非洲选定地点扩大心血管疾病预防干预措施包):一项实施研究项目。
Front Health Serv. 2024 May 7;4:1152410. doi: 10.3389/frhs.2024.1152410. eCollection 2024.
8
Synthetic Health Data Can Augment Community Research Efforts to Better Inform the Public During Emerging Pandemics.合成健康数据可助力社区研究工作,以便在新发大流行期间更好地为公众提供信息。
medRxiv. 2023 Dec 13:2023.12.11.23298687. doi: 10.1101/2023.12.11.23298687.
9
Smoking and pre-existing co-morbidities as risk factors for developing severity of COVID-19 infection: Evidence from a field hospital in a rural area of Bangladesh.吸烟和并存的合并症是导致 COVID-19 感染严重程度的危险因素:来自孟加拉国农村地区野战医院的证据。
PLoS One. 2023 Dec 8;18(12):e0295040. doi: 10.1371/journal.pone.0295040. eCollection 2023.
10
Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complications.内皮细胞激活和损伤作为不同病理学和细胞治疗并发症中的常见病理基础。
Front Med (Lausanne). 2023 Nov 14;10:1285898. doi: 10.3389/fmed.2023.1285898. eCollection 2023.
Nat Rev Nephrol. 2020 Jun;16(6):305-307. doi: 10.1038/s41581-020-0279-4.
4
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up.2019 年冠状病毒病在老年患者中的特征和预后因素:基于 4 周随访的研究。
J Infect. 2020 Jun;80(6):639-645. doi: 10.1016/j.jinf.2020.03.019. Epub 2020 Mar 30.
5
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.2019 年冠状病毒病患者中某些基础健康状况的初步估计——美国,2020 年 2 月 12 日至 3 月 28 日。
MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):382-386. doi: 10.15585/mmwr.mm6913e2.
6
Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis.新冠疫情期间急性肾损伤潜在机制的鉴定:一项基于单细胞转录组分析的研究
Intensive Care Med. 2020 Jun;46(6):1114-1116. doi: 10.1007/s00134-020-06026-1. Epub 2020 Mar 31.
7
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.西雅图地区危重症新冠患者-病例系列。
N Engl J Med. 2020 May 21;382(21):2012-2022. doi: 10.1056/NEJMoa2004500. Epub 2020 Mar 30.
8
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.COVID-19 感染癌症患者的临床特征:中国武汉三家医院的回顾性病例研究。
Ann Oncol. 2020 Jul;31(7):894-901. doi: 10.1016/j.annonc.2020.03.296. Epub 2020 Mar 26.
9
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).COVID-19 患者的致命结局对心血管的影响。
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
10
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.113 例新冠肺炎死亡患者的临床特征:回顾性研究。
BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091.